NDC 50419-542 – Kerendia
Finerenone 40 mg/1 · Tablet · Oral
Product NDC50419-542
Product details
- Brand name
- Kerendia
- Generic name
- finerenone
- Labeler
- Bayer HealthCare Pharmaceuticals Inc.
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- NDA · NDA215341
- Marketed since
- July 9, 2021
- Listing expires
- December 31, 2026
- Pharmacologic class
- Nonsteroidal Mineralocorticoid-Receptor Antagonist
Active ingredients
- Finerenone 40 mg/1
Package NDC codes (4)
| Package NDC | Description | Since |
|---|---|---|
| 50419-542-01 | 30 TABLET in 1 BOTTLE, PLASTIC (50419-542-01) | Jul 11, 2025 |
| 50419-542-02 | 90 TABLET in 1 BOTTLE, PLASTIC (50419-542-02) | Jul 11, 2025 |
| 50419-542-06 | 10 TABLET in 1 BLISTER PACK (50419-542-06) | Jul 11, 2025 |
| 50419-542-70 | 7 TABLET in 1 BOTTLE, PLASTIC (50419-542-70) | Jul 11, 2025 |